Skip to main content
. 2018 Oct 17;41(1):77–86. doi: 10.3892/or.2018.6803

Figure 1.

Figure 1.

Osimertinib inhibits cell proliferation. Cells were treated with osimertinib 1 h prior to irradiation, and the cell viability was determined by (A) MTS assay following 3 days of treatment, and (B) CFA following 14 days of treatment. The experiments were repeated 3 imes. Data are presented as the mean ± standard error of the mean. MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; CFA, clone fraction assay; DMSO, dimethyl sulfoxide; SER, sensitizer enhancement ratio.